T01-P-024 The effect of rosiglitazone on fibrinogen levels and platelet count in patients with type 2 diabetes and hypertension

Autor: Sarafidis, P., Lasaridis, A., Yovost, J., Mousleh, Z., Kazakos, A., Makedou-Kourti, K., Pliakos, C., Stafilas, P., Tourkantonis, A., Nilsson, P.
Zdroj: In Atherosclerosis (Supplements) (Component) 2005 6(1):139-139
Databáze: ScienceDirect